According to TechFlow TechFlow, on January 7th, YZi Labs posted on social media expressing its disappointment with BNC's board of directors' "poison pill" plan and the amendments to the articles of association that restrict shareholders' written consent, as a major shareholder of CEA Industries (NASDAQ: BNC). YZi Labs believes these measures are aimed at consolidating the board's own position rather than protecting shareholder interests.
YZi Labs refuted BNC's claim that it "never considered alternative tokens," pointing out that BNC CEO David Namdar clearly stated at an industry conference in November 2025 that the company had considered switching to other crypto assets such as Solana.
YZi Labs has filed a preliminary consent statement with the U.S. Securities and Exchange Commission seeking to expand the size of BNC's board of directors and elect its nominated directors. YZi Labs calls on the board to ensure a fair and transparent nomination and election process for the 2025 annual shareholder meeting.
